{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:38:52Z","timestamp":1790674732421,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Centro de Investigaci\u00c3\u00b3n Biom\u00c3\u00a9dica en Red Enfermedades Cardiovasculares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["SAF2017-88076-R"],"award-info":[{"award-number":["SAF2017-88076-R"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["CB06\/05\/0054"],"award-info":[{"award-number":["CB06\/05\/0054"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2017SGR717"],"award-info":[{"award-number":["2017SGR717"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2015-67474-R"],"award-info":[{"award-number":["SAF2015-67474-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013754","name":"Fondation pour la recherche juridique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.biopsych.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:21:49Z","timestamp":1552429309000},"page":"196-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington\u2019s Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-0708","authenticated-orcid":false,"given":"Veronica","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5334-0963","authenticated-orcid":false,"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Royes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4043-0457","authenticated-orcid":false,"given":"Marc","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Sieiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Antoine","family":"Girault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY)","volume":"85","author":"Van Duijn","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mds.22412","article-title":"Health-related quality of life in Huntington\u2019s disease: Which factors matter most?","volume":"24","author":"Ho","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2003-38093","article-title":"Fluoxetine-induced exacerbation of chorea in Huntington\u2019s disease? A case report","volume":"36","author":"Chari","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington\u2019s disease: Clinical presentation and treatment","volume":"98","author":"Novak","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-cellbio-092910-154023","article-title":"Cyclin-dependent kinases in brain development and disease","volume":"27","author":"Su","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1523\/JNEUROSCI.18-16-06370.1998","article-title":"Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex","volume":"18","author":"Gilmore","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1523\/JNEUROSCI.21-17-06758.2001","article-title":"P35 and P39 are essential for cyclin-dependent kinase 5 function during neurodevelopment","volume":"21","author":"Ko","year":"2001","journal-title":"J\u00a0Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.biopsych.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/cercor\/bhj172","article-title":"Role of p35\/Cdk5 in preplate splitting in the developing cerebral cortex","volume":"16","author":"Raki\u0107","year":"2006","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2006.02.024","article-title":"Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases","volume":"50","author":"Cheung","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainresbull.2010.11.016","article-title":"The role of Cdk5 in cognition and\u00a0neuropsychiatric and neurological pathology","volume":"85","author":"Barnett","year":"2011","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: The role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1007\/s12035-017-0828-4","article-title":"Cdk5 contributes to Huntington\u2019s disease learning and memory deficits via modulation of brain region-specific substrates","volume":"55","author":"Alvarez-Periel","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1038\/tp.2015.72","article-title":"Acute and chronic stress differentially regulate cyclin-dependent kinase 5 in mouse brain: implications to glucocorticoid actions and major depression","volume":"5","author":"Papadopoulou","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12031-014-0254-2","article-title":"Hippocampal glycogen synthase kinase 3\u03b2 is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats","volume":"54","author":"Li","year":"2014","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1017\/S1461145711000915","article-title":"Increased Cdk5\/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats","volume":"15","author":"Zhu","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nlm.2013.06.016","article-title":"Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment","volume":"105","author":"Su","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.biopsych.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nn.4066","article-title":"The role of ventral striatal cAMP signaling in stress-induced behaviors","volume":"18","author":"Plattner","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1523\/JNEUROSCI.3673-13.2014","article-title":"Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors","volume":"34","author":"Zhong","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in\u00a0the\u00a0Huntington\u2019s disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","article-title":"Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice","volume":"15","author":"Lloret","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.1089681","article-title":"Diverse psychotomimetics act through a common signaling pathway","volume":"302","author":"Svenningsson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.03.001_bib22","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/cddis.2011.2","article-title":"Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer\u2019s disease","volume":"2","author":"Crews","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.biopsych.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1172\/JCI74809","article-title":"Neurotrophin receptor p75 NTR mediates Huntington\u2019s disease\u2013associated synaptic and memory dysfunction","volume":"124","author":"Brito","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","article-title":"Mild cognitive impairment in prediagnosed Huntington disease","volume":"75","author":"Duff","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","article-title":"Psychiatric disorders in preclinical Huntington\u2019s disease","volume":"78","author":"Julien","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioural problems in Huntington\u2019s disease using the Problem Behaviours Assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington\u2019s disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","article-title":"A\u00a0role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease","volume":"24","author":"Puigdell\u00edvol","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2019.03.001_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12035-018-1126-5","article-title":"Early downregulation of p75NTR by genetic and pharmacological approaches delays the onset of motor deficits and striatal\u00a0dysfunction in Huntington\u2019s disease mice","volume":"56","author":"Suelves","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-0173(81)90005-9","article-title":"Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain","volume":"3","author":"Weiss","year":"1981","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.biopsych.2019.03.001_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.03.001_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neubiorev.2008.11.005","article-title":"Stress-induced prefrontal reorganization and executive dysfunction in rodents","volume":"33","author":"Holmes","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2019.03.001_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11920-012-0322-7","article-title":"Where in the brain is depression?","volume":"14","author":"Pandya","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2019.03.001_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1139\/jpn.0441","article-title":"The role of the hippocampus in the\u00a0pathophysiology of major depression","volume":"29","author":"Campbell","year":"2004","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib37","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.052712799","article-title":"Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)","volume":"99","author":"Svenningsson","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.03.001_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/45251","article-title":"Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons","volume":"402","author":"Bibb","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.03.001_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/35066591","article-title":"Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5","volume":"410","author":"Bibb","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.03.001_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2016.09.007","article-title":"Emerging role for nucleus accumbens medium spiny neuron subtypes in depression","volume":"81","author":"Francis","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1515\/RNS.2011.044","article-title":"Structural and synaptic plasticity in stress-related disorders","volume":"22","author":"Christoffel","year":"2011","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2015.01.022","article-title":"Spine synapse remodeling in the pathophysiology and treatment of depression","volume":"601","author":"Duman","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.03.001_bib43","doi-asserted-by":"crossref","first-page":"8056370","DOI":"10.1155\/2016\/8056370","article-title":"Dendritic spines in depression: What we learned from animal models","volume":"2016","author":"Qiao","year":"2016","journal-title":"Neural Plast"},{"key":"10.1016\/j.biopsych.2019.03.001_bib44","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1038\/ncomms10099","article-title":"DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons","volume":"6","author":"Engmann","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.03.001_bib45","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/MCB.18.3.1416","article-title":"Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase","volume":"18","author":"Cauthron","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","article-title":"DARPP-32: An integrator of neurotransmission","volume":"44","author":"Svenningsson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1371\/journal.pcbi.0020176","article-title":"DARPP-32 is a robust integrator of dopamine and glutamate signals","volume":"2","author":"Fernandez","year":"2006","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","article-title":"Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation","volume":"507","author":"Orvoen","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.03.001_bib49","doi-asserted-by":"crossref","first-page":"28322","DOI":"10.1038\/srep28322","article-title":"Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington\u2019s disease","volume":"6","author":"Soylu-Kucharz","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2019.03.001_bib50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-1781(01)00257-8","article-title":"Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington\u2019s disease gene carriers","volume":"102","author":"Berrios","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2019.03.001_bib51","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib52","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2019.03.001_bib53","doi-asserted-by":"crossref","first-page":"4056383","DOI":"10.1155\/2018\/4056383","article-title":"Antidepressant effects of probucol on early-symptomatic YAC128 transgenic mice for Huntington\u2019s disease","volume":"2018","author":"de Paula Nascimento-Castro","year":"2018","journal-title":"Neural Plast"},{"key":"10.1016\/j.biopsych.2019.03.001_bib54","doi-asserted-by":"crossref","first-page":"7201\u20147215","DOI":"10.1007\/s12035-018-0890-6","article-title":"Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington\u2019s disease mice","volume":"55","author":"da Fons\u00eaca","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib55","doi-asserted-by":"crossref","first-page":"41570","DOI":"10.1038\/srep41570","article-title":"Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111\/+ model of Huntington\u2019s disease","volume":"7","author":"Bragg","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2019.03.001_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0010-440X(92)90007-D","article-title":"The role of dopamine in mood disorders","volume":"33","author":"Diehl","year":"1992","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I","article-title":"The serotonin transporter and depression","volume":"8","author":"Owens","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2019.03.001_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrn2284","article-title":"Targeting the murine serotonin transporter: Insights into human neurobiology","volume":"9","author":"Murphy","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.03.001_bib60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1212\/WNL.0000000000001915","article-title":"Serotonin\/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia","volume":"85","author":"Huot","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2019.03.001_bib61","doi-asserted-by":"crossref","first-page":"e18336","DOI":"10.1371\/journal.pone.0018336","article-title":"Altered dopamine and serotonin metabolism in motorically asymptomatic R6\/2 mice","volume":"6","author":"Mochel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2019.03.001_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2013.00114","article-title":"Dopamine imbalance in Huntington\u2019s disease: A mechanism for the lack of behavioral flexibility","volume":"7","author":"Chen","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib63","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","article-title":"The neurobiology of slow synaptic transmission","volume":"294","author":"Greengard","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.03.001_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fncel.2013.00012","article-title":"Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice","volume":"7","author":"Yamamura","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib65","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1073\/pnas.0308652100","article-title":"Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum","volume":"101","author":"Chergui","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.03.001_bib66","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2019.03.001_bib67","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","article-title":"Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in\u00a0vivo microenvironment","volume":"25","author":"Phillips","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib68","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","article-title":"Neurogenesis in the R6\/1 transgenic mouse model of Huntington\u2019s disease: Effects of environmental enrichment","volume":"23","author":"Lazic","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib69","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2004.04.011","article-title":"Neurogenesis and depression: Etiology or epiphenomenon?","volume":"56","author":"Henn","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biopsych.2019.03.001_bib71","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1038\/cddis.2013.116","article-title":"Imbalance of p75NTR\/TrkB protein expression in Huntington\u2019s disease: Implication for neuroprotective therapies","volume":"4","author":"Brito","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.biopsych.2019.03.001_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2016.00037","article-title":"Impaired TrkB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6\/2 mouse model of Huntington\u2019s disease","volume":"10","author":"Nguyen","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib73","first-page":"303","article-title":"Modulating neurotrophin receptor signaling as a therapeutic strategy for Huntington\u2019s disease","volume":"6","author":"Simmons","year":"2017","journal-title":"J\u00a0Huntingtons Dis"},{"key":"10.1016\/j.biopsych.2019.03.001_bib74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib75","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.191353898","article-title":"Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors","volume":"98","author":"Liu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.03.001_bib76","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1073\/pnas.220410397","article-title":"Amplification of dopaminergic signaling by a positive feedback loop","volume":"97","author":"Nishi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.03.001_bib77","doi-asserted-by":"crossref","first-page":"ra119","DOI":"10.1126\/scisignal.aac7695","article-title":"Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine","volume":"8","author":"Gassen","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/j.biopsych.2019.03.001_bib78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbadis.2017.11.012","article-title":"CDK5-mediated phosphorylation of Sirt2 contributes to depressive-like behavior induced by social defeat stress","volume":"1864","author":"Zhang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.biopsych.2019.03.001_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2019.03.001_bib80","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","article-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders","volume":"48","author":"Jankovic","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2019.03.001_bib81","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","article-title":"Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression","volume":"33","author":"Nunes","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib82","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1523\/JNEUROSCI.4763-10.2011","article-title":"IB kinase regulates social defeat stress-induced synaptic and behavioral plasticity","volume":"31","author":"Christoffel","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.03.001_bib83","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/npp.2012.121","article-title":"Effects of inhibitor of kappaB kinase activity in the nucleus accumbens on emotional behavior","volume":"37","author":"Christoffel","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.03.001_bib84","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1038\/tp.2013.39","article-title":"Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens","volume":"3","author":"Bessa","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib85","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mds.870110318","article-title":"Complex movement disorders induced by fluoxetine","volume":"11","author":"Bharucha","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2019.03.001_bib86","first-page":"412","article-title":"Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.biopsych.2019.03.001_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.11.021","article-title":"Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies","volume":"117","author":"Lorenzetti","year":"2009","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2019.03.001_bib88","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/appi.ajp.2008.08081201","article-title":"Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder","volume":"166","author":"Pizzagalli","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2019.03.001_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm.3090","article-title":"Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression","volume":"19","author":"Golden","year":"2013","journal-title":"Nat Med"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319301519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319301519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:02:16Z","timestamp":1762099336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322319301519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0006322319301519"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.03.001","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington\u2019s Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}